Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 20, 2019
Pharmacy Choice - News - Drug Delivery Systems - March 20, 2019

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

3/13/19 - Drug Delivery Technology Market Outlook, Competitive Landscape and Forecasts to 2026
Albany, NY 03/12/2019 The technique or procedure used to deliver drugs or pharmaceuticals to a targeted site with the aim of curative solution is called as drug delivery. An active pharmaceutical component is the main element of any drug composition; however, the process of drug delivery plays an essential role in influencing the safety and e
3/13/19 - Exclusive speaker interview with SCHOTT Pharmaceutical Systems released for Pre-Filled Syringes East Coast 2019
LONDON, UNITED KINGDOM, March 13, 2019/ SMi Group reports: Senior expert from SCHOTT Pharmaceutical Systems is set to present at Pre-Filled Syringes East Coast Conference in just four weeks time in Boston, USA. The 6th Annual Pre-Filled Syringes East Coast conference is returning to Boston, USA in April 8th 9th 2019. The t
3/13/19 - Overlooked ingredients in medicines can sometimes trigger side effects
If you have a bad reaction to a medicine, it might not be the drug itself, but what are called "inactive ingredients" in the pill or capsule. For example, a few years ago study co-author Giovanni Traverso, a gastroenterologist at Harvard-affiliated Brigham and Women's Hospital, came across a patient with a severe gluten intolerance called celiac di
3/12/19 - Adlons ADHD treatment approved but with black box warning [Tehran Times (Iran)]
The US Food and Drug Administration approval for Aldon Therapeutics Adhansia XR extended-release capsules comes with a black box warning against possible risks associated with the drug. A spokesperson for Purdue Pharma subsidiary, Adlon, told us that Methylphenidate is a commonly used central nervous system stimulant for the treatment of...
You should read the following discussion in conjunction with Item 1 A. and our audited consolidated financial statements included elsewhere in this annual report. Some of the statements in the following discussion are forward-looking statements. Antares Pharma, Inc. is a combination drug device company focused primarily on the development and...
3/12/19 - Bronchitis Drug Market Insight by 2025: Top Players- AstraZeneca Plc,Merck & Co Inc,Mucosis BV,Orbis Biosciences Inc,DBV Technologie: This report studies the Bronchitis Drug market size (value and volume) by players, regions, product types and end in
New York, NY 03/11/2019 The Top key vendors in Bronchitis Drug Market include are Advanced Inhalation Therapies Ltd, AstraZeneca Plc, DBV Technologies SA, F. Hoffmann-La Roche Ltd, Han Wha Pharma Co Ltd, Kyorin Pharmaceutical Co Ltd, Merck& Co Inc, Mucosis BV, Orbis Biosciences Inc, Therabron Therapeutics Inc. Get Free PDF Sample Copy of Bron
3/12/19 - CURE Pharmaceutical Expands U.S. DEA Approval to Manufacture Pharmaceuticals Using Whole Cannabis Plant
CURE Pharmaceutical, an innovative drug delivery and development company, today announced it has broadened its U.S. Drug Enforcement Administration license as an authorized manufacturer of Schedule 1 substances to include both cannabis plant extracts and synthetic cannabidiol. This license approval significantly expands the potential formulati
3/12/19 - CytRx Corporation's Subsidiary, Centurion BioPharma Corporation's Albumin Companion Diagnostic (ACDx), Could Be The First To Personalize Medicine For Albumin-Based Drug Delivery Systems
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology treatment and diagnostics, and its private, wholly-owned subsidiary Centurion BioPharma Corporation, today announced the publication of peer reviewed, scientific research for its Albumin Companion Diagnostic. According to the National Cancer...
3/12/19 - Findings on Transdermal Delivery Discussed by Investigators at Department of Materials Science & Engineering (Fabrication of Microporous Inorganic Microneedles By Centrifugal Casting Method for Transdermal Extraction and Delivery): Drugs and Therapie
2019 MAR 12 By a News Reporter-Staff News Editor at Middle East Daily Current study results on Drugs and Therapies- Transdermal Delivery have been published. According to news originating from Qazvin, Iran, by NewsRx correspondents, research stated, Microneedle patches have been widely used as transdermal transport systems because of their p
3/12/19 - Global Medical Processing Seals Market 2019-2023 - The Miniaturization of Medical Devices Presents Lucrative Opportunities
The "Medical Processing Seals Market by Material, Type, Application, and Region- Global Forecast to 2023" report has been added to' s offering. The medical processing seals market size is estimated to be USD 1.4 billion in 2018 and is projected to reach USD 1.8 billion by 2023, at a CAGR of 5%. High consumption of medical e
3/12/19 - Janssen Pharmaceutical - New Phase 3 Stelara Data Show Positive Results as Maintenance Therapy in Adults with Moderate to Severe Ulcerative Colitis
Copenhagen- The Janssen Pharmaceutical Companies of Johnson& Johnson today announced new data from the Phase 3 UNIFI study showing that a significantly greater proportion of adult patients with moderate to severe ulcerative colitis receiving STELARA subcutaneous maintenance therapy were in clinical remission1 at one year, the study's primary...
3/12/19 - Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
WATERTOWN- Kala Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY mucus-penetrating particle Drug Delivery Technology, today reported financial results for the fourth quarter and full year ended December 31, 2018. Launched INVELTYSTM 1% in January 2019.
3/12/19 - Laurus Labs receives two approvals from USFDA
Laurus Labs Ltd is pleased to announce that the Company has recently received a final approval from United States Food and Drug Administration for Hydroxychloroquine Tablets 200 mg which is used for treatment of certain type of Malaria. Hydroxychloroquine Tabs 200 Mg is therapeutically equivalent to Plaquenil Tablets 200 mg of Concordia...
3/12/19 - Liposome Drug Delivery Market Outlook (2019-2025) : Johnson & Johnson, Gilead Sciences, Pa: QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting grou
Los Angeles, CA 03/12/2019 The report is a powerful tool that market participants can use to cement a strong position in the global Liposome Drug Delivery market. It comprises in-depth analysis that enables readers to receive a sound understanding of the growth and other critical factors that define the global Liposome Drug Delivery market.
3/12/19 - New Drug Delivery Systems Data Have Been Reported by Investigators at University of Jordan (Tunable Sustained Release Drug Delivery System Based On Mononuclear Aqueous Core-polymer Shell Microcapsules): Drugs and Therapies - Drug Delivery Systems
2019 MAR 12 By a News Reporter-Staff News Editor at Middle East Daily Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. Financial support for this research came from Scientific Research Support Fund, Jordan. For more information on this research see: Tunable Sustained Release Drug Delivery System Based On Mononucle
3/12/19 - ROMEG Therapeutics Receives FDA Approval of GLOPERBA colchicine for Prophylaxis of Adult Gout Flares: ROMEG Therapeutics
2019 MAR 12 By a News Reporter-Staff News Editor at CDC& FDA Daily ROMEG Therapeutics, an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, announced that the U.S. Food and Drug Administration approved GLOPERBA Oral Solution, 0.6 mg/5 mL for prophylaxis of gout flares in adults
3/12/19 - Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 764198 in Healthy Male Subjects (Single-blind, Partially Randomised, Placebo-controlled, Parallel Group Design): Clinical Trial Identifier NCT03854552
2019 MAR 12 By a News Reporter-Staff News Editor at Clinical Trials Daily Staff editors report on the newly launched clinical trial, NCT03854552, which has the following summary description: The main objective of this trial is to investigate safety and tolerability of BI 764198 in healthy male subjects following oral administration of single
3/12/19 - Self-Administered Medication Market: Manufacturers Concentrate on Improved Drug Delivery Device: As treatment of chronic diseases such as asthma, arthritis and gastrointestinal bespeak frequent visit to hospital and regular vaccinations, it might lea
Rockville, MD 03/12/2019 It is imperative all health care professionals and care workers appreciate the need for consumers to maintain their liberty with the administration of their medicines. When it comes to team approach, self-administered medications has been an added advantage to health care professionals, consumer and care workers.
3/12/19 - Self-Injection Device Market Report Examines Latest Trends and Key Drivers Supporting Growth Through 2026: Report starts with a comprehensive executive summary followed by market background section. The report also includes technological advancements
Albany, NY 03/11/2019 At the time when new biologic and bio-similar products are launching, the significance of self-injection devices for biopharmaceuticals have strengthened. Self-injection devices, including pen injectors, auto injectors and new large volume patch injectors have been designed for convenience and improved patient adherence.
3/12/19 - The 2019 Global Novel Drug Delivery Systems (NDDS) Market: Projected to Record a CAGR of 2.9% During 2018-2023 Stability Issues are Hampering Growth -
The "Novel Drug Delivery Systems Market- Segmented by Route of Administration, Mode of NDDS, Geography- Growth, Trends, and Forecast" report has been added to' s offering. The novel drug delivery systems market is expected to witness a CAGR of 2.9%, during the forecast period, 2018-2023. There is a continuous growth in the ma
3/12/19 - The medical processing seals market size is estimated to be USD 1.4 billion in 2018 and is projected to reach USD 1.8 billion by 2023, at a CAGR of 5.0%
High consumption of medical equipment& devices in North America due to the presence of a strong healthcare industry in the region is favorable for the medical processing seals market. This overall growth in the medical equipment application is expected to drive the medical processing seals market. O-rings type of medical processing seals accounted
3/11/19 - Alcyone Lifesciences Receives Breakthrough Device Designation from U.S. FDA for the ThecaFlex DRx? System
Alcyone Lifesciences, Inc., a leader in advanced technologies to treat complex neurological and oncological conditions through the company's proprietary advanced precision delivery platforms, announced today that the U.S. Food and Drug Administration has granted Breakthrough Device Designation for its ThecaFlex DRx? System. Richard S. Finkel, M
3/11/19 - Findings from Chongqing University of Posts and Telecommunications in Drug Delivery Systems Reported (Flexible Substrate-based Thermo-responsive Valve Applied In Electromagnetically Powered Drug Delivery System): Drugs and Therapies - Drug Delivery S
2019 MAR 11 By a News Reporter-Staff News Editor at NewsRx Drug Daily Current study results on Drugs and Therapies- Drug Delivery Systems have been published. According to news reporting from Chongqing, People s Republic of China, by NewsRx journalists, research stated, This paper presents a novel drug delivery system consisting of an ele
3/11/19 - Findings from Technical University Broaden Understanding of Nanoparticles (Biocompatible Coatings From Smart Biopolymer Nanoparticles for Enzymatically Induced Drug Release): Nanotechnology - Nanoparticles
2019 MAR 11 By a News Reporter-Staff News Editor at Nanotech Daily Current study results on Nanotechnology- Nanoparticles have been published. According to news reporting originating in Braunschweig, Germany, by NewsRx journalists, research stated, Nanoparticles can be used as a smart drug delivery system, when they release the drug only upo
3/11/19 - Findings on Tissue Engineering Detailed by Investigators at Ankara University (Tissue Scaffolds As a Local Drug Delivery System for Bone Regeneration): Biomedical Engineering - Tissue Engineering
2019 MAR 11 By a News Reporter-Staff News Editor at NewsRx Drug Daily New research on Biomedical Engineering- Tissue Engineering is the subject of a report. For more information on this research see: Tissue Scaffolds As a Local Drug Delivery System for Bone Regeneration. CUTTING-EDGE ENABLING TECHNOLOGIES FOR REGENERATIVE MEDICINE, 2018; 1078:
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement